Stem cell-based implants successfully secrete insulin in patients with type 1 diabetes
December 2, 2021
Interim results from a multicenter clinical trial demonstrate insulin secretion from engrafted cells in patients with type 1 diabetes. The safety, tolerability, and efficacy of the implants, which consisted of pancreatic endoderm cells derived from human pluripotent stem cells (PSCs), were tested in 26 patients. While the insulin secreted by the implants did not have clinical effects in the patients, the data are the first reported evidence of meal-regulated insulin secretion by differentiated stem cells in human patients.
Modecate Treatment review, Moditen-Depot, Fluphenazine Decanoate, ProlixinCare must be taken when undergoing Moditen Depot treatment. In the early days, nothing happens. Then, on the 3rd – 5th day, there comes a moment of sensation of Read more…